Published in Am Heart J on July 01, 2010
Natriuretic peptides for the detection of paroxysmal atrial fibrillation in patients with cerebral ischemia--the Find-AF study. PLoS One (2012) 0.95
Age-dependent yield of screening for undetected atrial fibrillation in stroke patients: the Find-AF study. J Neurol (2013) 0.84
Predictors for atrial fibrillation detection after cryptogenic stroke: Results from CRYSTAL AF. Neurology (2015) 0.82
Detection of occult atrial fibrillation by pacemaker interrogation in cryptogenic stroke. J Interv Card Electrophysiol (2014) 0.81
How and When to Screen for Atrial Fibrillation after Stroke: Insights from Insertable Cardiac Monitoring Devices. J Stroke (2016) 0.81
Detection of paroxysmal atrial fibrillation in stroke/tia patients. Stroke Res Treat (2013) 0.79
Paroxysmal atrial fibrillation in cryptogenic stroke. Ther Clin Risk Manag (2011) 0.79
The Role of Pharmacogenetics in Atrial Fibrillation Therapeutics: Is Personalized Therapy in Sight? J Cardiovasc Pharmacol (2016) 0.76
Brain-heart axis--Review Article. J Med Life (2015) 0.76
How to use implantable loop recorders in clinical trials and hybrid therapy. J Interv Card Electrophysiol (2011) 0.76
Identification of paroxysmal atrial fibrillation also for primary prevention of embolic stroke. Am Heart J (2010) 0.75
The Role of Continuous Monitoring in Atrial Fibrillation Management. Arrhythm Electrophysiol Rev (2014) 0.75
Relevance of Monitoring Atrial Fibrillation in Clinical Practice. Arrhythm Electrophysiol Rev (2012) 0.75
Stroke: finding atrial fibrillation after cryptogenic stroke. Nat Rev Neurol (2012) 0.75
Home Screening for Detecting Subclinical Atrial Fibrillation. J Atr Fibrillation (2015) 0.75
[Diagnosis of atrial fibrillation. From the standard ECG to analysis of electrograms]. Herzschrittmacherther Elektrophysiol (2013) 0.75
Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med (2009) 39.97
Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet (2010) 11.25
Subclinical atrial fibrillation and the risk of stroke. N Engl J Med (2012) 11.11
Apixaban in patients with atrial fibrillation. N Engl J Med (2011) 9.97
Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med (2015) 9.58
Telmisartan to prevent recurrent stroke and cardiovascular events. N Engl J Med (2008) 7.25
Approaches to catheter ablation for persistent atrial fibrillation. N Engl J Med (2015) 6.68
Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial. Circulation (2011) 6.48
Migraine and risk of cardiovascular disease in women. JAMA (2006) 6.16
Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. N Engl J Med (2008) 6.08
MRI profile and response to endovascular reperfusion after stroke (DEFUSE 2): a prospective cohort study. Lancet Neurol (2012) 5.91
Idarucizumab for Dabigatran Reversal. N Engl J Med (2015) 5.91
Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med (2014) 5.44
NXY-059 for acute ischemic stroke. N Engl J Med (2006) 5.32
Defibrillator implantation early after myocardial infarction. N Engl J Med (2009) 5.25
Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial. JAMA (2005) 4.60
Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis. J Am Coll Cardiol (2005) 4.40
Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. N Engl J Med (2004) 4.39
OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program. Headache (2010) 4.37
Chagas disease: an overview of clinical and epidemiological aspects. J Am Coll Cardiol (2013) 3.76
NXY-059 for the treatment of acute ischemic stroke. N Engl J Med (2007) 3.70
Discerning the incidence of symptomatic and asymptomatic episodes of atrial fibrillation before and after catheter ablation (DISCERN AF): a prospective, multicenter study. JAMA Intern Med (2013) 3.56
Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trial. JAMA (2005) 3.54
Intracranial hemorrhage in atrial fibrillation patients during anticoagulation with warfarin or dabigatran: the RE-LY trial. Stroke (2012) 3.02
Using dabigatran in patients with stroke: a practical guide for clinicians. Stroke (2011) 2.97
Placebo-controlled, randomized clinical trial of azimilide for prevention of ventricular tachyarrhythmias in patients with an implantable cardioverter defibrillator. Circulation (2004) 2.81
Infarct morphology identifies patients with substrate for sustained ventricular tachycardia. J Am Coll Cardiol (2005) 2.80
Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF. Lancet Neurol (2012) 2.77
Frovatriptan for prophylactic treatment of cluster headache: lessons for future trial design. Headache (2010) 2.72
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J (2016) 2.70
Implantable cardioverter-defibrillator shock prevention does not reduce mortality: a systemic review. Heart Rhythm (2012) 2.65
Response of atrial fibrillation to pulmonary vein antrum isolation is directly related to resumption and delay of pulmonary vein conduction. Circulation (2005) 2.56
Migraine and risk of cardiovascular disease in men. Arch Intern Med (2007) 2.49
Responsiveness of efficacy endpoints in clinical trials with over the counter analgesics for headache. Cephalalgia (2012) 2.46
Risks for stroke, bleeding, and death in patients with atrial fibrillation receiving dabigatran or warfarin in relation to the CHADS2 score: a subgroup analysis of the RE-LY trial. Ann Intern Med (2011) 2.45
Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation. Europace (2015) 2.35
Dopamine-dependent changes in the functional connectivity between basal ganglia and cerebral cortex in humans. Brain (2002) 2.15
Movement-related changes in synchronization in the human basal ganglia. Brain (2002) 2.15
Cardiac histological substrate in patients with clinical phenotype of Brugada syndrome. Circulation (2005) 2.10
Migraine, migraine aura, and cervical artery dissection: a systematic review and meta-analysis. Cephalalgia (2011) 2.07
The clinical diagnostic utility of transcranial magnetic stimulation: report of an IFCN committee. Clin Neurophysiol (2007) 2.05
Obesity and recurrent vascular risk after a recent ischemic stroke. Stroke (2011) 2.04
Atrial fibrillation ablation using a robotic catheter remote control system: initial human experience and long-term follow-up results. J Am Coll Cardiol (2008) 2.02
Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial. Lancet Neurol (2012) 1.99
Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas' cardiomyopathy: the BENznidazole Evaluation For Interrupting Trypanosomiasis (BENEFIT). Am Heart J (2008) 1.99
Reduced platelet activity is associated with early clot growth and worse 3-month outcome after intracerebral hemorrhage. Stroke (2009) 1.96
Existing motor state is favored at the expense of new movement during 13-35 Hz oscillatory synchrony in the human corticospinal system. J Neurosci (2005) 1.93
Sudden cardiac death and dialysis patients. Semin Dial (2008) 1.92
Predicting functional outcome and survival after acute ischemic stroke. J Neurol (2002) 1.92
Outcome parameters for trials in atrial fibrillation: executive summary. Eur Heart J (2007) 1.90
Cluster headache: clinical presentation, lifestyle features, and medical treatment. Headache (2006) 1.86
Cryoballoon versus RF ablation in paroxysmal atrial fibrillation: results from the German Ablation Registry. J Cardiovasc Electrophysiol (2013) 1.84
Safety and tolerability of NXY-059 for acute intracerebral hemorrhage: the CHANT Trial. Stroke (2007) 1.75
Randomized comparison between open irrigation technology and intracardiac-echo-guided energy delivery for pulmonary vein antrum isolation: procedural parameters, outcomes, and the effect on esophageal injury. J Cardiovasc Electrophysiol (2007) 1.73
Oscillatory activity in the pedunculopontine area of patients with Parkinson's disease. Exp Neurol (2008) 1.71
Heart rate variability in athletes. Sports Med (2003) 1.70
Dipyridamole for preventing recurrent ischemic stroke and other vascular events: a meta-analysis of individual patient data from randomized controlled trials. Stroke (2004) 1.69
Cluster headache: clinical features and therapeutic options. Dtsch Arztebl Int (2011) 1.69
Physiology of repetitive transcranial magnetic stimulation of the human brain. Brain Stimul (2009) 1.68
Cost comparison of catheter ablation and medical therapy in atrial fibrillation. J Cardiovasc Electrophysiol (2007) 1.67
Acute treatment of migraine with the selective 5-HT1F receptor agonist lasmiditan--a randomised proof-of-concept trial. Cephalalgia (2010) 1.67
Efficacy and tolerability of lasmiditan, an oral 5-HT(1F) receptor agonist, for the acute treatment of migraine: a phase 2 randomised, placebo-controlled, parallel-group, dose-ranging study. Lancet Neurol (2012) 1.67
Pulmonary-vein isolation for atrial fibrillation in patients with heart failure. N Engl J Med (2008) 1.65
Role of the implantable defibrillator among elderly patients with a history of life-threatening ventricular arrhythmias. Eur Heart J (2007) 1.63
Association of left atrial fibrosis detected by delayed-enhancement magnetic resonance imaging and the risk of stroke in patients with atrial fibrillation. J Am Coll Cardiol (2011) 1.63
Impact of resting heart rate on mortality, disability and cognitive decline in patients after ischaemic stroke. Eur Heart J (2012) 1.62
A systematic review of randomized trials comparing radiofrequency ablation with antiarrhythmic medications in patients with atrial fibrillation. J Cardiovasc Electrophysiol (2008) 1.59
Congestive heart failure in Latin America: the next epidemic. Am Heart J (2004) 1.58
Early platelet transfusion improves platelet activity and may improve outcomes after intracerebral hemorrhage. Neurocrit Care (2012) 1.55
The BENEFIT trial: testing the hypothesis that trypanocidal therapy is beneficial for patients with chronic Chagas heart disease. Mem Inst Oswaldo Cruz (2009) 1.54
Lipopolysaccharide transport to the bacterial outer membrane in spheroplasts. J Biol Chem (2004) 1.53
Predictors of treatment in acute coronary syndromes in the elderly: impact on decision making and clinical outcome after interventional versus conservative treatment. Catheter Cardiovasc Interv (2012) 1.53
Influence of age on outcome from thrombolysis in acute stroke: a controlled comparison in patients from the Virtual International Stroke Trials Archive (VISTA). Stroke (2010) 1.53
Canadian Registry of ICD Implant Testing procedures (CREDIT): current practice, risks, and costs of intraoperative defibrillation testing. J Cardiovasc Electrophysiol (2009) 1.53
Age of first faint in patients with vasovagal syncope. J Cardiovasc Electrophysiol (2006) 1.52
Secondary stroke prevention with ximelagatran versus warfarin in patients with atrial fibrillation: pooled analysis of SPORTIF III and V clinical trials. Stroke (2007) 1.52
Prevention of medication overuse in patients with migraine. Pain (2010) 1.51
Dabigatran etexilate for stroke prevention in patients with atrial fibrillation: resolving uncertainties in routine practice. Thromb Haemost (2012) 1.51
Ablation of atrioventricular nodal reentrant tachycardia in the elderly: results from the German Ablation Registry. Heart Rhythm (2011) 1.51
Slow wall motion rather than electrical conduction delay underlies mechanical dyssynchrony in postinfarction patients with narrow QRS complex. J Cardiovasc Electrophysiol (2009) 1.50
"Near-zero" fluoroscopic exposure in supraventricular arrhythmia ablation using the EnSite NavX™ mapping system: personal experience and review of the literature. J Interv Card Electrophysiol (2011) 1.49
Device-related infection among patients with pacemakers and implantable defibrillators: incidence, risk factors, and consequences. J Cardiovasc Electrophysiol (2010) 1.48
Assessment of functioning and disability after ischemic stroke. Stroke (2002) 1.48
R-wave peak time at DII: a new criterion for differentiating between wide complex QRS tachycardias. Heart Rhythm (2010) 1.48
Standardized approaches to the investigation of syncope: Canadian Cardiovascular Society position paper. Can J Cardiol (2011) 1.47
Incidence and significance of early recurrences associated with different ablation strategies for AF: a STAR-AF substudy. J Cardiovasc Electrophysiol (2012) 1.44
Endovascular stroke therapy: a single-center retrospective review. Neurosurg Focus (2011) 1.44
Amplification of acute focal ischemic deficit by narcotics. Neurocrit Care (2008) 1.44